A systematic review of dozens of studies has revealed that levels of the five most prevalent HMOs in breast milk vary widely, and infant formula development should accommodate this variability.
You May Also Like

Global conference on infant nutrition in Wellington
INCOctober 17, 2022

US formula shortage: FDA refutes claims of postponing all applications under discretion policy
INCAugust 30, 2022

‘Possible opportunity’: ANZ infant nutrition firms gear up for US market entry amid formula shortage
INCJune 27, 2022